A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma.
Saved in:
| Title: | A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma. |
|---|---|
| Authors: | Dileo R; Division of Hematology and Cellular Therapy, Allegheny Health Network, Pittsburgh, PA, 15222, USA., Mewawalla P; Division of Hematology and Cellular Therapy, Allegheny Health Network, Pittsburgh, PA, 15222, USA., Babu K; Division of Hematology and Cellular Therapy, Allegheny Health Network, Pittsburgh, PA, 15222, USA., Yin Y; Allegheny-Singer Research Institute, Allegheny Health Network, Pittsburgh, PA, USA., Strouse C; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa City, IA, USA., Chen E; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa City, IA, USA., Shaikh H; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa City, IA, USA., Davis JA; Department of Hematology-Oncology, Medical University of South Carolina, Charleston, SC, USA., Green KM; Department of Hematology-Oncology, Medical University of South Carolina, Charleston, SC, USA., Alkharabsheh O; University of South Alabama Mitchell Cancer Institute, Mobile, AL, USA., Rashid A; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, MO, USA., Pokhrel B; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, MO, USA., Ahmed N; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, MO, USA., Abdallah AO; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, MO, USA., Hashmi H; Department of Hematology-Oncology, Medical University of South Carolina, Charleston, SC, USA. hashmih1@mskcc.org.; Myeloma & Cell Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. hashmih1@mskcc.org. |
| Source: | Blood cancer journal [Blood Cancer J] 2025 Mar 10; Vol. 15 (1), pp. 34. Date of Electronic Publication: 2025 Mar 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-025-01226-8 |
